Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
Antimicrob Agents Chemother ; 65(9): e0025721, 2021 08 17.
Artigo em Inglês | MEDLINE | ID: mdl-34228547

RESUMO

Methicillin-resistant Staphylococcus aureus (MRSA) colonization leads to increased infection rates and mortality. Decolonization treatment has been proven to prevent infection and reduce transmission. As the optimal antimicrobial strategy is yet to be established, different regimens are currently prescribed to patients. This study aimed to evaluate the efficacy of the decolonization treatments recommended by the Dutch guideline. A retrospective multicenter cohort study was conducted in five Dutch hospitals. All patients who visited the outpatient clinic because of complicated MRSA carriage between 2014 and 2018 were included. We obtained data on patient characteristics, clinical and microbiological variables relevant for MRSA decolonization, environmental factors, decolonization regimen, and treatment outcome. The primary outcome was defined as three negative MRSA cultures after treatment completion. Outcomes were stratified for the first-line treatment strategies. A total of 131/224 patients were treated with systemic antibiotic agents. Treatment was successful in 111/131 (85%) patients. The success rate was highest in patients treated with doxycycline-rifampin (32/37; 86%), but the difference from any of the other regimens did not reach statistical significance. There was no difference in the success rate of a 7-day treatment compared to that with 10 to 14 days of treatment (odds ratio [OR], 0.99; 95% confidence interval [CI], 0.39 to 2.53; P = 1.00). Side effects were reported in 27/131 (21%) patients and consisted mainly of mild gastrointestinal complaints. In a multivariable analysis, an immunocompromised status was an independent risk factor for failure at the first treatment attempt (OR, 4.65; 95% CI, 1.25 to 17.25; P = 0.02). The antimicrobial combinations recommended to treat complicated MRSA carriage yielded high success rates. Prolonged treatment did not affect treatment outcome. A randomized trial is needed to resolve whether the most successful regimen in this study (doxycycline plus rifampin) is superior to other combinations.


Assuntos
Staphylococcus aureus Resistente à Meticilina , Infecções Estafilocócicas , Antibacterianos/uso terapêutico , Portador Sadio/tratamento farmacológico , Estudos de Coortes , Humanos , Estudos Retrospectivos , Infecções Estafilocócicas/tratamento farmacológico
2.
Ned Tijdschr Geneeskd ; 161: D1372, 2017.
Artigo em Holandês | MEDLINE | ID: mdl-28612695

RESUMO

Peritoneal tuberculosis was diagnosed in a 38-year-old man from Curaçao, a 42-year-old Dutch man and a 38-year-old woman from Surinam. All patients had been living in the Netherlands for over a decade at the time of diagnosis. Time to diagnosis and treatment varied between patients. Factors contributing to delayed diagnosis were nonspecific symptoms, failure to consider tuberculosis exposure, consulting of more than one physician and delay in obtaining adequate material for histopathologic and microbiologic tests. These cases show that peritoneal tuberculosis can represent a diagnostic challenge. Considering the rising incidence of tuberculosis in the Netherlands, general practitioners and medical specialists will encounter patients with extrapulmonary tuberculosis more frequently. We recommend that tuberculosis exposure should always be considered by clinicians, even in patients originating from non-endemic countries. In case of suspected peritoneal tuberculosis, laparoscopy with peritoneal biopsy is the diagnostic tool of choice and should be performed without delay.


Assuntos
Peritônio/patologia , Peritonite Tuberculosa/diagnóstico , Adulto , Biópsia , Curaçao , Diagnóstico Tardio , Emigrantes e Imigrantes , Feminino , Humanos , Incidência , Laparoscopia , Masculino , Países Baixos , Suriname , Tuberculose
3.
Int J Hematol ; 93(6): 811-814, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21557043

RESUMO

The present report describes repeated long-term remissions of a high-grade T cell lymphoma in an HIV-positive patient upon cART only, without additional chemotherapy. A review of cases from the literature further illustrates the anti-tumor effects of cART through the induction of a strong immune reconstitution in HIV-infected patients.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Linfoma Relacionado a AIDS/tratamento farmacológico , Linfoma Relacionado a AIDS/patologia , Linfoma de Células T/tratamento farmacológico , Linfoma de Células T/patologia , Terapia Antirretroviral de Alta Atividade , Osso e Ossos/patologia , Contagem de Linfócito CD4 , Infecções por HIV/complicações , Humanos , Linfoma Relacionado a AIDS/diagnóstico , Linfoma de Células T/diagnóstico , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Tomografia por Emissão de Pósitrons , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Carga Viral
4.
Bone Marrow Transplant ; 37(7): 693-8, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16501590

RESUMO

The efficacy and safety of oral valganciclovir was compared to ganciclovir i.v. in pre-emptive treatment of cytomegalovirus (CMV) in T-cell-depleted allogeneic stem cell transplant (allo-SCT) recipients. A therapeutic guideline was developed to allow the safe application of valganciclovir in allo-SCT recipients requiring CMV therapy. In total, 107 consecutive transplant recipients were evaluated. Cytomegalovirus DNA load in plasma was monitored longitudinally; details on antiviral therapy and treatment responses were analyzed retrospectively. Fifty-seven CMV treatment episodes were recorded in 34 patients: 20 with valganciclovir (900 mg twice-daily) and 37 with ganciclovir (5 mg/kg twice-daily). Median CMV DNA load reduction was 0.079 and 0.069 log10 copies/ml/day in the ganciclovir and valganciclovir group, respectively. Good response on CMV DNA load (reduction below 3.0 log10 copies/ml) was observed in 75.7% of ganciclovir and 80.0% of valganciclovir treatment episodes. Severe adverse effects were not observed and CMV-related disease did not occur. However, the percentage of patients receiving erythrocyte transfusion was higher in the group of patients receiving ganciclovir as compared to valganciclovir (41 versus 20%, P=0.116). In conclusion, pre-emptive treatment with valganciclovir and ganciclovir, led to similar reduction of CMV DNA load. Oral valganciclovir is an attractive and safe alternative for pre-emptive CMV treatment in T-cell-depleted allo-SCT recipients.


Assuntos
Infecções por Citomegalovirus/prevenção & controle , DNA Viral/sangue , Ganciclovir/análogos & derivados , Ganciclovir/administração & dosagem , Transplante de Células-Tronco , Carga Viral , Administração Oral , Adulto , Antivirais/administração & dosagem , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Feminino , Humanos , Injeções Intravenosas , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de Risco , Transplante de Células-Tronco/efeitos adversos , Transplante de Células-Tronco/métodos , Condicionamento Pré-Transplante , Transplante Homólogo , Resultado do Tratamento , Valganciclovir
5.
Eur J Echocardiogr ; 6(5): 388-91, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16153561

RESUMO

The current report describes a case of a primary cardiac lymphoma. For early and appropriate treatment of a cardiac mass it is not only important to determine its localization and extension but also to differentiate between malignant and benign lesions. This report demonstrates that not only transthoracic echocardiography but also the other different forms of echocardiography such as transesophageal echocardiography, as well as contrast and intracardiac echocardiography, are useful tools in the diagnostic workup of cardiac masses.


Assuntos
Ecocardiografia Transesofagiana , Ecocardiografia , Neoplasias Cardíacas/diagnóstico por imagem , Linfoma Difuso de Grandes Células B/diagnóstico por imagem , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Átrios do Coração/diagnóstico por imagem , Neoplasias Cardíacas/tratamento farmacológico , Neoplasias Cardíacas/patologia , Ventrículos do Coração/diagnóstico por imagem , Humanos , Linfoma Difuso de Grandes Células B/tratamento farmacológico , Linfoma Difuso de Grandes Células B/patologia , Masculino , Pessoa de Meia-Idade
6.
Ned Tijdschr Geneeskd ; 148(32): 1577-81, 2004 Aug 07.
Artigo em Holandês | MEDLINE | ID: mdl-15382556

RESUMO

Linezolid is the first of a new class of antibacterial agents, the oxazolidinones, to become available. Linezolid has a unique mechanism of action in its inhibition of bacterial protein synthesis in Gram-positive and a number of anaerobic bacteria. Because of this unique mechanism of action, linezolid exhibits no cross-resistance with other antibiotics and is effective against methicillin-resistant staphylococci, penicillin-resistant pneumococci and vancomycin-resistant enterococci. The excellent bioavailability after oral administration (almost 100%) makes it suitable for outpatient treatment and treatment by general practitioners. In the Netherlands, however, the indications for linezolid are limited by its high cost, the availability of other effective antibiotics for the treatment of sensitive micro-organisms, and the toxicity associated with a prolonged treatment period. Resistance to the new agent was reported rather quickly after the introduction of linezolid.


Assuntos
Acetamidas/uso terapêutico , Anti-Infecciosos/uso terapêutico , Bactérias Gram-Positivas/efeitos dos fármacos , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Oxazolidinonas/uso terapêutico , Acetamidas/administração & dosagem , Acetamidas/economia , Acetamidas/farmacocinética , Administração Oral , Anti-Infecciosos/administração & dosagem , Anti-Infecciosos/economia , Anti-Infecciosos/farmacocinética , Bactérias Anaeróbias/efeitos dos fármacos , Disponibilidade Biológica , Farmacorresistência Bacteriana , Humanos , Linezolida , Testes de Sensibilidade Microbiana , Oxazolidinonas/administração & dosagem , Oxazolidinonas/economia , Oxazolidinonas/farmacocinética
7.
Ned Tijdschr Geneeskd ; 148(25): 1221-6, 2004 Jun 19.
Artigo em Holandês | MEDLINE | ID: mdl-15301382

RESUMO

Syphilis was diagnosed in three men having sex with men, aged 36, 38 and 58 years, who had a variety of skin lesions and other symptoms. In a woman aged 38 years and her 39-year-old husband, syphilis was found during routine pregnancy screening. All patients were successfully treated with intramuscular (benzathin) benzylpenicillin. Early recognition and treatment as well as advice on avoiding high-risk sexual behaviour are important in preventing further spread of the disease. Although generally the risk of HIV transmission during unprotected oral sexual contact is believed to be low, the transmission of Treponema pallidum during this type of contact is possible and is probably the most important transmission route amongst men having sex with men.


Assuntos
Antibacterianos/uso terapêutico , Penicilina G/uso terapêutico , Sífilis/diagnóstico , Adulto , Feminino , Homossexualidade Masculina , Humanos , Masculino , Pessoa de Meia-Idade , Países Baixos/epidemiologia , Gravidez , Complicações Infecciosas na Gravidez/diagnóstico , Complicações Infecciosas na Gravidez/tratamento farmacológico , Complicações Infecciosas na Gravidez/epidemiologia , Fatores de Risco , Comportamento Sexual , Sífilis/tratamento farmacológico , Sífilis/epidemiologia
10.
Ned Tijdschr Geneeskd ; 147(9): 403-6, 2003 Mar 01.
Artigo em Holandês | MEDLINE | ID: mdl-12661461

RESUMO

A 58-year-old woman was admitted due to a pseudomembranous pharyngitis. The patient had not been vaccinated against diphtheria. Corynebacterium ulcerans was cultured from a throat swab. The production of diphtheria toxin by these bacteria was demonstrated with PCR and an immunoprecipitation test. The patient was cared for in respiratory isolation and was treated with benzylpenicillin. She quickly recovered and was discharged four days after admission. A contact investigation did not reveal any dissemination of the toxin-producing C. ulcerans and a source was not found. In spite of the large-scale vaccination against diphtheria which has taken place in the Netherlands since 1953, a physician has to consider diphtheria in the differential diagnosis of patients who present with a clinical syndrome compatible with this disease. Either Corynebacterium diphtheriae or C. ulcerans could be the pathogen responsible.


Assuntos
Corynebacterium/isolamento & purificação , Difteria/diagnóstico , Penicilina G/uso terapêutico , Penicilinas/uso terapêutico , Faringite/microbiologia , Corynebacterium/patogenicidade , Diagnóstico Diferencial , Difteria/tratamento farmacológico , Difteria/microbiologia , Toxina Diftérica/biossíntese , Feminino , Humanos , Pessoa de Meia-Idade , Países Baixos , Faringite/diagnóstico , Faringite/tratamento farmacológico
12.
Ned Tijdschr Geneeskd ; 146(46): 2183-8, 2002 Nov 16.
Artigo em Holandês | MEDLINE | ID: mdl-12467160

RESUMO

Lassa, Ebola, Marburg and Crimean-Congo haemorrhagic fever viruses are the most important causes of viral haemorrhagic fever which is transmitted from person to person through contact with blood or excreta. A non-specific fever may be the initial symptom of viral haemorrhagic fever. By means of carefully noting where the patient has travelled, possible exposure to ill persons, vectors or an animal reservoir, and the incubation period (< or = 21 days versus longer), it is possible to estimate the risk of infection with one of these viruses. Using this approach it is possible to diagnose high-risk patients in good time and to take appropriate measures.


Assuntos
Febres Hemorrágicas Virais/diagnóstico , Febres Hemorrágicas Virais/terapia , Adulto , Antivirais/uso terapêutico , Feminino , Febre/etiologia , Febre Hemorrágica da Crimeia/diagnóstico , Febre Hemorrágica da Crimeia/terapia , Doença pelo Vírus Ebola/diagnóstico , Doença pelo Vírus Ebola/terapia , Humanos , Febre Lassa/diagnóstico , Febre Lassa/terapia , Doença do Vírus de Marburg/diagnóstico , Doença do Vírus de Marburg/terapia , Viagem
13.
Ned Tijdschr Geneeskd ; 146(46): 2201-4, 2002 Nov 16.
Artigo em Holandês | MEDLINE | ID: mdl-12467165

RESUMO

A 48-year-old-man returned to the Netherlands from Sierra Leone and was admitted with nausea, crampy abdominal pain, myalgia, arthralgia, headache and watery diarrhoea. This was the first case of Lassa fever diagnosed in the Netherlands since 1980. Despite treatment with ribavirin, the patient died on the 16th day of illness. Prompt diagnosis of Lassa fever is critical for the timely administration of ribavirin which improves diagnosis considerably, and for the timely implementation of isolation measures. Recently, a reverse transcriptase polymerase chain reaction (RT-PCR) has become available for the rapid diagnosis of acute Lassa fever, which was implemented to diagnose this patient.


Assuntos
Antivirais/uso terapêutico , Febre Lassa/diagnóstico , Ribavirina/uso terapêutico , Evolução Fatal , Humanos , Febre Lassa/tratamento farmacológico , Vírus Lassa/isolamento & purificação , Masculino , Pessoa de Meia-Idade , Países Baixos , RNA Viral/análise , RNA Viral/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Serra Leoa , Viagem
16.
Ned Tijdschr Geneeskd ; 142(30): 1714-9, 1998 Jul 25.
Artigo em Holandês | MEDLINE | ID: mdl-9763867

RESUMO

A 75-year-old woman was admitted because of fever of unknown origin (FUO). In the year before the current admission she developed myalgias and was treated for polymyalgia rheumatica with low-dose prednisone. Her complaints persisted and prednisone was discontinued. Five months before the present admission she developed fever (37.7-38.9 degrees C), malaise, fatigue and occipital headache. Laboratory tests showed an elevated erythrocyte sedimentation rate (98 mm in the first hour) and a severe hypochromic, slightly microcytic, anaemia. Although a recent temporal artery biopsy was negative, a second biopsy was taken which showed giant cell arteritis. The patient was treated with high-dose prednisone (60 mg daily) and made a full recovery. It is emphasized that temporal arteritis is a common cause of FUO in the elderly.


Assuntos
Febre de Causa Desconhecida/etiologia , Arterite de Células Gigantes/complicações , Arterite de Células Gigantes/diagnóstico , Idoso , Anemia Hipocrômica/complicações , Anemia Hipocrômica/diagnóstico , Biópsia , Sedimentação Sanguínea , Feminino , Arterite de Células Gigantes/tratamento farmacológico , Humanos , Polimialgia Reumática/diagnóstico , Polimialgia Reumática/tratamento farmacológico , Prednisona/uso terapêutico
17.
Ned Tijdschr Geneeskd ; 142(26): 1493-500, 1998 Jun 27.
Artigo em Holandês | MEDLINE | ID: mdl-9752068

RESUMO

An 82-year-old man was admitted because of abdominal pain and a shaking chill. His medical history revealed ileocecal resection because of ileitis associated with a Yersinia infection 3 years before admission. One year later he was readmitted because of bowel obstruction due to recurrent ileitis. He was treated with trimethoprim-sulfamethoxazole for two weeks because of positive serological tests for Yersinia and made a full recovery except for chronic diarrhoea. On the current admission, stool cultures yielded Campylobacter upsaliensis. Further analysis showed severe non-specific ulcerative ileitis without colitis. A diagnosis of Crohn's disease was made. The patient was treated with prednisone and mesalazine and made a full recovery. The chronic diarrhoea disappeared. The course was complicated by a cerebro-vascular thrombosis and severe thrombocytosis due to polycythaemia vera. Treatment with hydroxyurea was effective in lowering the thrombocyte count.


Assuntos
Doença de Crohn/diagnóstico , Dor Abdominal/etiologia , Idoso , Idoso de 80 Anos ou mais , Doença de Crohn/complicações , Doença de Crohn/tratamento farmacológico , Diagnóstico Diferencial , Quimioterapia Combinada , Humanos , Hidroxiureia/administração & dosagem , Ileíte/diagnóstico , Masculino , Mesalamina/administração & dosagem , Prednisona/administração & dosagem , Resultado do Tratamento
18.
Ned Tijdschr Geneeskd ; 142(48): 2622-6, 1998 Nov 28.
Artigo em Holandês | MEDLINE | ID: mdl-10028363

RESUMO

A 55-year-old man was admitted because of cholestatic jaundice. Extrahepatic obstruction and viral causes were excluded. A diagnosis of liver damage due to the combination preparation amoxicillin and clavulanic acid (Augmentin) was made. The patient had an uneventful recovery. It is pointed out that in case of cholestatic jaundice drug-induced cholestasis should be suspected early in the course. History taking is an important tool. If a suspected drug is found other causes of the disease can be excluded with simple tests.


Assuntos
Combinação Amoxicilina e Clavulanato de Potássio/efeitos adversos , Colestase/induzido quimicamente , Humanos , Masculino , Pessoa de Meia-Idade , Sinusite/tratamento farmacológico , Resultado do Tratamento
19.
Ned Tijdschr Geneeskd ; 142(50): 2732-6, 1998 Dec 12.
Artigo em Holandês | MEDLINE | ID: mdl-10065238

RESUMO

A 74-year-old woman was admitted because of abdominal pain. A few weeks before this admission she had had a cerebral infarction in the right hemisphere, reflected by a left sided paralysis, dysarthria, depression and a slight cognitive disorder. The night before admission she woke up from a sharp, continuous pain in the right upper abdomen. Physical examination disclosed pain in the right upper abdomen on palpation. Laboratory tests showed a slight elevation of all 'liver' enzymes. A differential diagnosis of cholecystitis or pyelonephritis was made. Additional tests did not confirm either of these diagnoses. Because of immobilisation pulmonary embolism was then suspected. This diagnosis was confirmed by scintigraphy. The patient was treated and made a full recovery. Diagnostic errors can be made by faulty triggering and omitting verification. The diagnostic strategy for pulmonary embolism is a ventilation perfusion scan, which is followed in case of a non high-probability result by pulmonary angiography. It is emphasized that the presentation of pulmonary embolism can be aspecific.


Assuntos
Dor Abdominal/etiologia , Erros de Diagnóstico , Embolia Pulmonar/complicações , Embolia Pulmonar/diagnóstico , Idoso , Angiografia , Infarto Cerebral/complicações , Colecistite/diagnóstico , Feminino , Humanos , Pulmão/diagnóstico por imagem , Pielonefrite/diagnóstico , Cintilografia , Relação Ventilação-Perfusão
20.
Infect Immun ; 60(1): 202-5, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1309512

RESUMO

The aim of the present study was to determine whether pertussis toxin (PT)-sensitive GTP-binding proteins (G proteins) are involved in the signal transduction pathway(s) used for phagocytosis and intracellular killing of bacteria by human granulocytes. Treatment of granulocytes with PT resulted in decreased phagocytosis of immunoglobulin G (IgG)-opsonized Staphylococcus aureus but did not affect subsequent intracellular killing of these bacteria. PT also caused a decrease in the extracellular release of superoxide anion (O2-) and hydrogen peroxide (H2O2) by granulocytes in response to S. aureus opsonized by IgG. However, neither the phagocytosis nor the intracellular killing of S. aureus opsonized by fresh serum was affected by PT, and the release of O2- was partially inhibited. The release of O2- in response to serum-treated zymosan, opsonized mainly by complement components, was also only partially inhibited by PT. It is therefore possible that PT inhibits responses mediated through complement receptors to a lesser extent than those mediated via Fc gamma receptors. The results of this study indicate that PT-sensitive G proteins are involved in the signal transduction pathways that mediate the phagocytosis of IgG-opsonized bacteria and the accompanying respiratory burst.


Assuntos
Citotoxicidade Imunológica/efeitos dos fármacos , Granulócitos/fisiologia , Imunidade Celular/efeitos dos fármacos , Toxina Pertussis , Fagocitose/efeitos dos fármacos , Staphylococcus aureus , Fatores de Virulência de Bordetella/farmacologia , Proteínas de Ligação ao GTP/fisiologia , Humanos , Peróxido de Hidrogênio/metabolismo , Técnicas In Vitro , Proteínas Opsonizantes , Explosão Respiratória/efeitos dos fármacos , Transdução de Sinais , Superóxidos/metabolismo , Zimosan/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...